Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs. mammography alone in women at elevated risk of breast cancer. JAMA 2008;299:2151-63.
Brem RF, Schoonjans JM, Kieper DA, et al. Highresolution scintimammography: a pilot study. J Nucl Med 2002;43:909-15.
Brem R, Kieper D. Rapelyea J, et al. Evaluation of a high-resolution, breast-specific, small-field-of-view gamma camera for the detection of breast cancer. Nuclear Instruments and Methods 2003;497:168-73.
Scopinaro F, Pani R, de Vincentis G, et al. High-resolution scintimammography improves the accuracy of Tc-99m methoxyisobutylisonitrile scintimammography:use of a new dedicated gamma camera. Eur J Nucl Med 1999;26:1279-88.
Garibaldi F, Cisbani E, Cusanno F, et al. Optimization of compact gamma cameras for breast imaging. Nucl. Instr. & Meth. Phys Res Sec A 2001;471:222.
Coover LR, Caravaglia G, Kuhn P. Scintimammography with dedicated breast camera detects and localizes occult carcinoma. J Nucl Med 2004;45:553-8.
Rhodes DJ, O’Connor MK, Phillips SW, et al. Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast. Mayo Clin Proc 2005;80:24-30.
O’Connor MK, Phillips SW, Hruska CB, et al. Molecular breast imaging: advantages and limitations of a scintimammographic technique in patients with small breast tumors. Breast J 2007;13:3-11.
Brem R, Kieper D, Rapelyea J, et al. High-Resolution Scintimammography as an Adjunct for the Diagnosis of Breast Cancer in High-Risk Women with Normal Mammograms and Physical Examination. RSNA Annual Meeting Chicago IL, December 1-5, 2003.
Wymer DC, Green T, Keppel C, et al. Evaluation of clinically occult mammographic abnormalities using scintimammography with enhanced gamma camera imaging. SNM Annual Meeting. New Orleans LA, June 21-25 2003.
Chen S. Liu W. Mao Y, et al. 99m Tc-MIBI and 99m Tc-MDP scintimammography for detecting breast carcinoma. Chin Med J 2000;113:400-3.
Pena Y, Coca MA, Perera A, et al. Use of Tc-99m glucoheptonate scintimammography as a potential alternative for the diagnosis of breast cancer. Clin Nucl Med 2005;30:126-7.
Goldsmith SJ, Parsons W, Guiberteau MJ, et al. Society of Nuclear Medicine. SNM practice guideline for breast scintigraphy with breast-spe- cific gamma-cameras 1.0. J Nucl Med Technol 2010; 38:219-24.
Carvalho PA, Chiu ML, Kronauge JF, et al. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992;33:1516-21.
Crane P, Laliberte R, Heminway S, et al. Effect of mitochondrial viability and metabolism on technetium- 99msestamibi myocardial retention. Eur J Nucl Med 1993;20:20-5.
Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (I) in cultured chick myocardial cells. Mito chondrial and plasma membrane potential dependence. Circulation 1990;82:1826-38.
Cutrone JA, Yospur LS, Khalkhali I, et al. Immunohisto logic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions. J Nucl Med 1998;39:449-53.
Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994;178:491-7.
Scopinaro F, Schillaci O, Scarpini M, et al. Technetium-99m sestamibi: an indicator of breast cancer invasiveness. Eur J Nucl Med 1994;21:984-7.
Piwnica-Worms D, Chiu ML, Budding M, et al. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993;53:977-84.
Ballinger JR, Hua HA, Berry BW, et al. 99Tcm-Sestamibi as an agent for imaging P-glycoprotein-mediated multidrug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant. Nucl Med Commun 1995;16:253-7.
Moretti JL, Caglar M, Boaziz C, et al. Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide:can we predict the response to chemotherapy in small cell lung cancer? Eur J Nucl Med 1995;22:177-80.
Kieper D, Green TD, Hoefer R, et al. Data analysis methods for a small field-of-view combined scintimammography/digital X-ray system in breast lesion manage ment. Nucl Instr and Meth A 2003497:135-40.
Sciuto R, Pasqualoni R Bergomi S, et al. Germana. Prognostic Value of 99mTc-Sestamibi Washout in Predicting Response of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy. J Nucl Med 2002;43:745-51.
Hruska CB, O’Connor MK, Collins DA. Comparison of small field of view gamma camera systems for scintimammography. Nucl Med Commun 2006:441-5.
Hruska C, et al. Molecular Breast Imaging: Use of a Dual-Head Dedicated Gamma Camera to Detect Small Breast Tumors. AJR 2008;191:1805-15.
Böhm-Vélez M, Kieper DA, Williams MB, et al. A Clinical Evaluation of Breast Tissue Uptake of Tc99m-Sestamibi as a Function of Injected Dose. Breast Cancer Imaging:State of the Art 2011. National Institutes of Health, Washington DC. April 2011.
SNM Guideline for Breast Scintigraphy with Breast-Specific Gamma Cameras 1.0. Society of Nuclear Medicine. Issued June 4, 2010. http://interactive.snm.org/docs/BreastScintigraphyGuideline_V1.0.pdf
Del Vecchio S, Salvatore M. 99mTc-MIBI in the evaluation of breast cancer biology. Eur J Nucl Med Mol Imaging 2004;31(Suppl. 1):88-96.
The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007;37:1-332.
Hendrick E. Radiation doses and cancer risks from breast imaging studies. Radiology 2010;257:246-53.
Radiation Dose in Perspective. Health Physics Society via web search. October 13th 2010. www.hps.org/documents/radiationrisk.pdf
NIH RSC Report: Improving Informed Consent for Research Radiation Studies. Published October 17, 2001. Web search conducted October 4, 2010. http://drs.ors. od.nih.gov/services/rsc/forms/informed_consent.pdf
